Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Naomi W. Lucchi"'
Autor:
Catherine Bakari, Celine I. Mandara, Rashid A. Madebe, Misago D. Seth, Billy Ngasala, Erasmus Kamugisha, Maimuna Ahmed, Filbert Francis, Samwel Bushukatale, Mercy Chiduo, Twilumba Makene, Abdunoor M. Kabanywanyi, Muhidin K. Mahende, Reginald A. Kavishe, Florida Muro, Sigsbert Mkude, Renata Mandike, Fabrizio Molteni, Frank Chacky, Dunstan R. Bishanga, Ritha J. A. Njau, Marian Warsame, Bilali Kabula, Ssanyu S. Nyinondi, Naomi W. Lucchi, Eldin Talundzic, Meera Venkatesan, Leah F. Moriarty, Naomi Serbantez, Chonge Kitojo, Erik J. Reaves, Eric S. Halsey, Ally Mohamed, Venkatachalam Udhayakumar, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background Therapeutic efficacy studies (TESs) and detection of molecular markers of drug resistance are recommended by the World Health Organization (WHO) to monitor the efficacy of artemisinin-based combination therapy (ACT). This study as
Externí odkaz:
https://doaj.org/article/bbdfbdb13b094de59208ee4c4414aa68
Autor:
Angela Patricia Guerra, Mario Javier Olivera, Liliana Jazmín Cortés, Stella M. Chenet, Alexandre Macedo de Oliveira, Naomi W. Lucchi
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Resistance to anti-malarial drugs is associated with polymorphisms in target genes and surveillance for these molecular markers is important to detect the emergence of mutations associated with drug resistance and signal recoverin
Externí odkaz:
https://doaj.org/article/6169c05e95c24cf2968bdd61706848f7
Autor:
Rispah Abdallah, Jaime Louzada, Christina Carlson, Dragan Ljolje, Venkatachalam Udhayakumar, Joseli Oliveira-Ferreira, Naomi W. Lucchi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract The state of Roraima, in Brazil, has recently seen an increase in the number of reported Plasmodium falciparum infections believed to be imported from neighboring countries. The objective of this study was to determine the prevalence of Plas
Externí odkaz:
https://doaj.org/article/c1963f275d3e4d298866f8e4f2b4edb2
Autor:
Chris Ebong, Asadu Sserwanga, Jane Frances Namuganga, James Kapisi, Arthur Mpimbaza, Samuel Gonahasa, Victor Asua, Sam Gudoi, Ruth Kigozi, James Tibenderana, John Bosco Bwanika, Agaba Bosco, Denis Rubahika, Daniel Kyabayinze, Jimmy Opigo, Damian Rutazana, Gloria Sebikaari, Kassahun Belay, Mame Niang, Eric S. Halsey, Leah F. Moriarty, Naomi W. Lucchi, Samaly S. Svigel Souza, Sam L. Nsobya, Moses R. Kamya, Adoke Yeka
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background In Uganda, artemether-lumefantrine (AL) is first-line therapy and dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated malaria. This study evaluated the efficacy and safety of AL and DP in the
Externí odkaz:
https://doaj.org/article/8528def3450848f184ccf4ee0df58e73
Autor:
Catherine M. Dentinger, Tovonahary Angelo Rakotomanga, Antsa Rakotondrandriana, Arinomenjanahary Rakotoarisoa, Marie Ange Rason, Leah F. Moriarty, Laura C. Steinhardt, Laurent Kapesa, Jocelyn Razafindrakoto, Samaly S. Svigel, Naomi W. Lucchi, Venkatachalam Udhayakumar, Eric S. Halsey, C. Arsène Ratsimbasoa
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background Since 2005, artemisinin-based combination therapy (ACT) has been recommended to treat uncomplicated falciparum malaria in Madagascar. Artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) are the first- and second-line tr
Externí odkaz:
https://doaj.org/article/df32110b281d46a280c7dd012b62afec
Autor:
Arlindo Chidimatembue, Samaly S. Svigel, Alfredo Mayor, Pedro Aíde, Abel Nhama, Lídia Nhamussua, Arsénio Nhacolo, Quique Bassat, Crizólgo Salvador, Sónia Enosse, Abuchahama Saifodine, Eva De Carvalho, Baltazar Candrinho, Rose Zulliger, Ira Goldman, Venkatachalam Udhayakumar, Naomi W. Lucchi, Eric S. Halsey, Eusébio Macete
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-9 (2021)
Abstract Background Due to the threat of emerging anti-malarial resistance, the World Health Organization recommends incorporating surveillance for molecular markers of anti-malarial resistance into routine therapeutic efficacy studies (TESs). In 201
Externí odkaz:
https://doaj.org/article/7693976e046d498eb51bb172cfe049ba
Autor:
Sarah E. Schmedes, Dhruviben Patel, Simran Dhal, Julia Kelley, Samaly S. Svigel, Pedro Rafael Dimbu, Adicatou-Laï Adeothy, Gauthier Mesia Kahunu, Papy Mandoko Nkoli, Abdoul Habib Beavogui, Simon Kariuki, Don P. Mathanga, Ousmane Koita, Deus Ishengoma, Ally Mohamad, Moonga Hawela, Leah F. Moriarty, Aaron M. Samuels, Julie Gutman, Mateusz M. Plucinski, Venkatachalam Udhayakumar, Zhiyong Zhou, Naomi W. Lucchi, Meera Venkatesan, Eric S. Halsey, Eldin Talundzic
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 7, Pp 1902-1908 (2021)
The spread of drug resistance to antimalarial treatments poses a serious public health risk globally. To combat this risk, molecular surveillance of drug resistance is imperative. We report the prevalence of mutations in the Plasmodium falciparum kel
Externí odkaz:
https://doaj.org/article/4ca4aece9c33406d8814c20224b667b5
Autor:
Mariangela L’Episcopia, Julia Kelley, Bruna G. Djeunang Dongho, Dhruviben Patel, Sarah Schmedes, Shashidhar Ravishankar, Edvige Perrotti, David Modiano, Naomi W. Lucchi, Gianluca Russo, Eldin Talundzic, Carlo Severini
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss , Pp 234-241 (2021)
Background: Recent studies showed the first emergence of the R561H artemisinin-associated resistance marker in Africa, which highlights the importance of continued molecular surveillance to assess the selection and spread of this and other drug resis
Externí odkaz:
https://doaj.org/article/3b3187fa8bc94b8aa0a0022a5702eb68
Autor:
Youssouf Diarra, Oumar Koné, Lansana Sangaré, Lassina Doumbia, Dade Bouye Ben Haidara, Mouctar Diallo, Ababacar Maiga, Hamadoun A. Sango, Halidou Sidibé, Jules Mihigo, Douglas Nace, Dragan Ljolje, Eldin Talundzic, Venkatachalam Udhayakumar, Erin Eckert, Celia J. Woodfill, Leah F. Moriarty, Pharath Lim, Donald J. Krogstad, Eric S. Halsey, Naomi W. Lucchi, Ousmane A. Koita
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background The current first-line treatments for uncomplicated malaria recommended by the National Malaria Control Programme in Mali are artemether–lumefantrine (AL) and artesunate–amodiaquine (ASAQ). From 2015 to 2016, an in vivo study
Externí odkaz:
https://doaj.org/article/ce50d1a8576342ba839a66fb31f52bfd
Publikováno v:
BMC Research Notes, Vol 14, Iss 1, Pp 1-5 (2021)
Abstract Objective In this study, the performance of a commercially available malaria LAMP assay (Alethia® Malaria Plus LAMP) was evaluated using retrospective clinical samples obtained from travelers returning to the United States of America (USA).
Externí odkaz:
https://doaj.org/article/b30f0c9631f845eb8b6a6147a025f006